STOCK TITAN

Absci (ABSI) CLO awarded RSUs and 356,300-share option in Form 4

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Absci Corp Chief Legal Officer Shelby J. Walker reported equity awards and a related tax-withholding share disposition. On March 2, Walker received a grant of 90,300 shares of common stock as restricted stock units under Absci’s 2021 Stock Option and Incentive Plan, and a separate stock option covering 356,300 shares at an exercise price of $0.00 per share.

The RSUs and the option are scheduled to vest in three substantially equal annual installments beginning on March 1, 2027, subject to continued service. On March 3, 9,825 shares of common stock at $2.80 per share were withheld by Absci to cover tax obligations tied to RSU vesting, which the filing states was not a discretionary trade. After these transactions, Walker directly owned 139,775 shares of common stock.

Positive

  • None.

Negative

  • None.

Insights

Routine equity awards with tax withholding, no open-market trading.

Absci granted its Chief Legal Officer 90,300 restricted stock units and a 356,300-share stock option, both vesting over three years starting on March 1, 2027. These awards align the executive’s compensation with future company performance through time-based vesting.

The F-code transaction for 9,825 shares at $2.80 per share is explicitly described as shares withheld to satisfy tax obligations upon RSU vesting, not a discretionary sale. From an investor perspective, this is standard administrative activity and does not change the fundamental outlook.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Walker Shelby J.

(Last) (First) (Middle)
C/O ABSCI CORPORATION
18105 SE MILL PLAIN BLVD

(Street)
VANCOUVER WA 98683

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Absci Corp [ ABSI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Legal Officer
3. Date of Earliest Transaction (Month/Day/Year)
03/02/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 03/02/2026 A 90,300(1) A $0 149,600 D
Common Stock 03/03/2026 F 9,825(2) D $2.8 139,775 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (right to buy) $2.8 03/02/2026 A 356,300(3) (3) 02/29/2036 Common Stock 356,300 $0 356,300 D
Explanation of Responses:
1. The shares reported in this transaction represent Restricted Stock Units ("RSUs") issued under the Absci Corporation 2021 Stock Option and Incentive Plan. The RSUs shall vest and be settled in three substantially equal annual installments with the first such annual installment vesting on March 1, 2027, subject to the Reporting Person's continuous service to the Issuer on each such date.
2. Amount reported represents the number of shares withheld by the Issuer to cover the tax withholding obligation in connection with the vesting of these restricted stock units and does not represent a discretionary trade by the reporting person.
3. The shares subject to this option shall vest and become exercisable over a three year period, in substantially equal annual installments with the first such installment vesting on March 1, 2027, subject to the Reporting Person's continuous service to the Issuer on each such date.
Remarks:
/s/ Shelby Walker 03/04/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Absci (ABSI) Chief Legal Officer Shelby J. Walker receive in this Form 4 filing?

Shelby J. Walker received a grant of 90,300 restricted stock units and a stock option for 356,300 shares. Both awards were issued under Absci’s 2021 Stock Option and Incentive Plan as part of equity-based executive compensation, aligning incentives with the company’s long-term performance.

How do Shelby J. Walker’s new RSUs from Absci (ABSI) vest?

The 90,300 restricted stock units vest in three substantially equal annual installments starting March 1, 2027. Each installment is contingent on Walker’s continuous service with Absci on the relevant vesting date, meaning the awards are earned gradually over a multi-year period.

What are the terms of Shelby J. Walker’s new stock option reported by Absci (ABSI)?

Walker received a stock option covering 356,300 shares with a stated exercise price of $0.00 per share. The option vests in three substantially equal annual installments beginning March 1, 2027, subject to continued service, creating long-term exposure to Absci’s share performance.

Why did Absci (ABSI) withhold 9,825 shares from Shelby J. Walker?

Absci withheld 9,825 shares of common stock at $2.80 per share to cover tax withholding obligations related to RSU vesting. The filing specifies this was not a discretionary trade by Walker but an administrative share withholding for required tax payments.

How many Absci (ABSI) shares does Shelby J. Walker own after these Form 4 transactions?

Following the reported grant, vesting, and tax withholding transactions, Shelby J. Walker directly owns 139,775 shares of Absci common stock. This figure reflects the net balance after adding granted shares and subtracting those withheld to satisfy associated tax liabilities.
Absci Corp

NASDAQ:ABSI

ABSI Rankings

ABSI Latest News

ABSI Latest SEC Filings

ABSI Stock Data

399.99M
130.36M
Biotechnology
Services-commercial Physical & Biological Research
Link
United States
VANCOUVER